atlanta lawyers glp-1 medication lawsuits Lawsuit Attorneys | Ashenden & Associates GLP-1 Lawsuit Attorneys | Ashenden

DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006

As we await prospective data, clinical practice should consider the difference between abrupt stop vs gradual taper when counseling patients about expectations after therapy

The Australia GLP-1 receptor agonist market size was valued at USD 570.49 million in 2025 and is expected to hit around USD 2,117.46 million by 2035, growing at a CAGR of 14.01% from 2026 to 2035.

World Diabetes Day reminds us that diabetes isnt just about sugar - its about how our body uses energy

All patients with diabetes should have yearly eye exams

Apply the patch to clean, dry skin on areas such as the arm, back, waist, or thigh